Dr. Abdul-Mutakabbir explored the intersection of antibiotic resistance and health/vaccine equity, with a specific focus on racial differences observed across racially and ethnically minoritized groups. 

February 29, 2024
Rima Mycynek

UC San Diego’s Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP presented on “The Intersection of Racism, Antimicrobial Resistance, and Vaccine Equity” for a Black History Month seminar today, focusing on healthcare disparities observed across racially and ethnically minoritized groups. The talk was sponsored jointly by the Levy CIMAR, the Tufts Department of Molecular Biology and Microbiology Diversity, Equity, & Inclusion committee, and the Tufts Graduate School of Biomedical Sciences.

Among her many titles, Dr. Abdul-Mutakabbir is an Assistant Professor of Clinical Pharmacy at UC San Diego’s Skaggs School of Pharmacy and Pharmaceutical Sciences and in the Division of the Black Diaspora and African American Studies. Her research in mitigating antimicrobial resistance has led her to be recognized by the European Congress of Clinical Microbiology and Infectious Diseases as one of their 30 under 30 outstanding young scientists, for their ECCMID 2021 31st annual meeting. She is also dedicated to magnifying and rectifying health inequities in minoritized communities. To that point, she currently serves as the Lead Pharmacist and Educator for Congregations Organized for Prophetic Engagement-Health Equity Collaborative and was the 2023 recipient of the Infectious Disease Society of American Clinical Practice Innovation Award.

Dr. Abdul-Mutakabbir’s talk provided an overview of health equity principles, inequities observed in AMR, and the link to vaccine inequities. She explored a framework on how to incorporate equity into different facets of practice, both within and outside of the realm of infectious diseases practice.

Video: Exploring The Intersection Of Racism, Antimicrobial Resistance, And Vaccine Equity — UC San Diego’s Jacinda C. Abdul-Mutakabbir PharmD, MPH, AAHIVP